Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA
Clinical trial NCT05334576 · UNKNOWN
Trial details
- NCT number
- NCT05334576
- Sponsor
- Andria Ford
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-07-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.